Questo sito utilizza cookie tecnici e consente l'invio di cookie di "terze parti" al fine di effettuare misure di traffico per la valutazione delle prestazioni del sito. Per saperne di più, clicca sull'apposito bottone "Maggiori dettagli", che aprirà in modalità pop up l'informativa estesa, dove è possibile avere informazioni per negare il consenso all'installazione di qualunque cookie. Cliccando il bottone OK, o cliccando su una qualsiasi altra area del sito, presterai consenso all'uso dei cookie.

Comparisons between prosthetic vascular graft and saphenous vein graft in femoro-popliteal bypass.

Comparisons between prosthetic vascular graft and saphenous vein graft in femoro-popliteal bypass.

Park KM, Kim YW, Yang SS, Kim DI. 20 May 2015

Annals of Surgical Treatment and Research (2014)
Infrainguinalfemoropopliteal bypass (IFPB) is recommended to peripheral arterial disease (PAD) with a long occlusion of the superficial femoral artery (SFA). The aims of our study were to determine the patency of graft materials, and identify the risk factors of graft failure

Download abstract

Cryopreserved saphenous vein graft in infrainguinal bypass.

Cryopreserved saphenous vein graft in infrainguinal bypass.

Hartranft CA, Noland S, Kulwicki A, Holden CR, Hartranft T 06 November 2014

Journal of vascular surgery (2014)
Autogenous saphenous vein is the ideal conduit for lower extremity revascularization. Unfortunately, autogenous vein is unavailable in up to 20% of patients. Synthetic grafts provide an alternative; however, their use in distal revascularization has shown varying results. In addition, infected surgical sites preclude their use. Currently, there are limited outcome data for cryopreserved saphenous vein use in regard to long-term patency and limb salvage rates.

Download abstract

Saphenous vein graft intervention: status report 2014

Saphenous vein graft intervention: status report 2014

Soverow J, Lee MS. 06 December 2014

 2014 Dec;26(12):659-67.

Given their frequent use as bypass conduits and high rates of degeneration, saphenous vein grafts (SVGs) will continue to require percutaneous coronary intervention. Due to their unique physiology, SVGs pose special challenges to the interventionalist. Preintervention evaluation of hemodynamic significance is hampered by limited data and uncertainty regarding the validity of fractional flow reserve. Intraprocedural complications, particularly distal embolization and no-reflow, are common but may be mitigated by various techniques. Despite advances in the field, SVG intervention is associated with worse outcomes - including increased rates of periprocedural myocardial infarction, restenosis, target vessel revascularization, non-target disease progression, and death - compared with native vessel intervention. This paper reviews the most recent data and techniques available to the interventionalist seeking to improve outcomes after SVG intervention.

Download abstract